Maravai LifeSciences Holdings Inc (NAS:MRVI)
$ 7.175 0.165 (2.35%) Market Cap: 953.06 Mil Enterprise Value: 932.14 Mil PE Ratio: 0 PB Ratio: 2.31 GF Score: 82/100

Maravai LifeSciences Holdings Inc at Nasdaq Investor Conference (Virtual) Transcript

Nov 30, 2021 / 03:00PM GMT
Release Date Price: $45.94 (+6.34%)
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

Hello, everyone, and good morning. My name is Tejas Savant, and I'm the Life Sciences Analyst here at Morgan Stanley. It's my pleasure today to host a fireside chat with Kevin Herde, CFO of Maravai. Kevin, thanks for doing this.

Before we begin, just have a quick disclosure statement to rattle off here, for important disclosures, please see the Morgan Stanley research website at morganstanley.com/researchdisclosures. And if you have any questions, do reach out to your sales rep.

Questions & Answers

Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

So Kevin, perhaps just to set the stage, for folks on the call, who are not as familiar with the Maravai story. Could you just provide an overview of the portfolio? And what do you think is your competitive differentiation across each of the segments?

Kevin M. Herde
Maravai LifeSciences Holdings, Inc. - Executive VP & CFO

Yes, absolutely. So first of all,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot